World's Best Scientists 2026 revealed!
VIEW LIST
Tony Mok

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 135 2013 1874 14 12 790 110634

Tony Mok publications per year

The chart shows the history of publications by Tony Mok between 1997 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Tony Mok published across 29 years, from 1997 to 2025, averaging 36.2 papers a year. Output peaked at 111 publications in 2023. 138 of the 1,050 publications appeared in the last two years.

No. of publications
25 50 75 100
Bar chart. Horizontal axis: year, 1997 to 2025. Vertical axis: number of publications, 0 to 111. Peak 111 publications in 2023. 1997: 1 publication 1998: 4 publications 1999: 6 publications 2000: 7 publications 2001: 6 publications 2002: 9 publications 2003: 9 publications 2004: 18 publications 2005: 23 publications 2006: 18 publications 2007: 18 publications 2008: 27 publications 2009: 26 publications 2010: 25 publications 2011: 35 publications 2012: 48 publications 2013: 29 publications 2014: 46 publications 2015: 44 publications 2016: 65 publications 2017: 76 publications 2018: 63 publications 2019: 47 publications 2020: 47 publications 2021: 57 publications 2022: 47 publications 2023: 111 publications 2024: 70 publications 2025: 68 publications
1997 2025

1,050 publications in total across all disciplines

View publications per year as a table
Tony Mok: publications per year, 1997 to 2025
Year Publications
1997 1
1998 4
1999 6
2000 7
2001 6
2002 9
2003 9
2004 18
2005 23
2006 18
2007 18
2008 27
2009 26
2010 25
2011 35
2012 48
2013 29
2014 46
2015 44
2016 65
2017 76
2018 63
2019 47
2020 47
2021 57
2022 47
2023 111
2024 70
2025 68
Total 1,050
Download as CSV

Tony Mok publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Tony Mok sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 781–800 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 790 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217 790
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Tony Mok D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Tony Mok sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 134–135 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 135 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163 135
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Tony Mok is affiliated with the Chinese University of Hong Kong in China, focusing primarily on medical research within pulmonary and respiratory medicine as well as oncology. Their work concentrates significantly on lung cancer treatments, mutations, and diagnostic methods, reflecting expertise in the intersection of medical science and cancer research.

The scientist's research output is substantial in the field of medicine, covering a total of 619 publications. Key subfields of study include pulmonary and respiratory medicine with 305 publications, oncology with 234 publications, cancer research with 49 publications, molecular biology with 27 publications, and radiology, nuclear medicine, and imaging with 20 publications.

Main topics of their work center on lung cancer treatments and mutations (352 publications), cancer immunotherapy and biomarkers (152 publications), lung cancer research studies (148 publications), lung cancer diagnosis and treatment (142 publications), colorectal cancer treatments and studies (96 publications), cancer genomics and diagnostics (92 publications), and gastric cancer management and outcomes (42 publications).

Frequent co-authors collaborating with Tony Mok include:

  • Yi-Long Wu (61 joint publications)
  • Solange Peters (47 joint publications)
  • Byoung Chul Cho (29 joint publications)
  • Enriqueta Felip (28 joint publications)
  • Filippo de Marinis (27 joint publications)

The scientist has contributed extensively to several prominent journals. Notable publication venues include the Journal of Clinical Oncology with 44 publications, Annals of Oncology with 43 publications, Journal of Thoracic Oncology with 34 publications, Lung Cancer with 19 publications, and Cancer Research with 16 publications.

Selected recent papers authored or co-authored by Tony Mok are:

  • "First-Line Lorlatinib or Crizotinib in Advanced ALK -Positive Lung Cancer," 2020, New England Journal of Medicine
  • "Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)," 2021, Journal of Clinical Oncology
  • "Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up," 2023, Annals of Oncology
  • "Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study," 2020, Annals of Oncology
  • "Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer," 2021, Journal of Thoracic Oncology

Best Publications

  • Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

    Tony S. Mok;Yi Long Wu;Sumitra Thongprasert;Chih Hsin Yang

  • MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

    Jeffrey A. Engelman;Kreshnik Zejnullahu;Tetsuya Mitsudomi;Youngchul Song

  • Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer

    Alice T. Shaw;Dong Wan Kim;Kazuhiko Nakagawa;Takashi Seto

  • Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

    Lecia V. Sequist;James Chih-Hsin Yang;Nobuyuki Yamamoto;Kenneth John O'Byrne

  • First-line crizotinib versus chemotherapy in ALK-positive lung cancer

    Benjamin J. Solomon;Tony Shu-kam Mok;Dong Wan Kim;Yi Long Wu

  • Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.

    Tony S. Mok;Yi Long Wu;Myung Ju Ahn;Marina C. Garassino

  • Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

    Tony S.K. Mok;Yi Long Wu;Iveta Kudaba;Dariusz M. Kowalski

  • First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

    Leora Horn;Aaron S. Mansfield;Aleksandra Szczęsna;Libor Havel

  • Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer

    Solange Peters;D. Ross Camidge;Alice T. Shaw;Shirish Gadgeel

  • Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial

    Edward S. Kim;Vera Hirsh;Tony Mok;Mark A. Socinski

  • Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)

    Masahiro Fukuoka;Yi Long Wu;Sumitra Thongprasert;Patrapim Sunpaweravong

  • Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

    James Chih Hsin Yang;Yi Long Wu;Martin Schuler;Martin Sebastian

  • Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial

    Keunchil Park;Eng Huat Tan;Ken O'Byrne;Li Zhang

  • Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC

    Alexa B. Turke;Kreshnik Zejnullahu;Yi Long Wu;Youngchul Song

  • Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial.

    Yi-Long Wu;Ying Cheng;Xiangdong Zhou;Ki Hyeong Lee

  • Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab

    David R. Gandara;Sarah M. Paul;Marcin Kowanetz;Erica Schleifman

  • Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6.

    James C.H. Yang;Lecia V. Sequist;Sarayut Lucien Geater;Chun Ming Tsai

  • Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial.

    Martin Reck;Tony S K Mok;Makoto Nishio;Robert M Jotte

  • Osimertinib or platinum–pemetrexed in EGFR T790M–positive lung cancer

    T.S. Mok;Y.-L. Wu;M.-J. Ahn;M.C. Garassino

  • BiomarkerAnalysesandFinalOverallSurvivalResultsFroma PhaseIII,Randomized,Open-Label,First-LineStudyofGefitinib VersusCarboplatin/PaclitaxelinClinicallySelectedPatientsWith AdvancedNon-Small-CellLungCancerinAsia(IPASS)

    Masahiro Fukuoka;Yi-Long Wu;Sumitra Thongprasert;Patrapim Sunpaweravong

Frequent Co-Authors

Yi-Long Wu
Yi-Long Wu Guangdong Provincial People’s Hospital
Winnie Yeo
Winnie Yeo Chinese University of Hong Kong
James Chih-Hsin Yang
James Chih-Hsin Yang National Taiwan University
Kenneth J. O'Byrne
Kenneth J. O'Byrne Queensland University of Technology
Anthony T.C. Chan
Anthony T.C. Chan Chinese University of Hong Kong
Philip J. Johnson
Philip J. Johnson University of Liverpool
Luis Paz-Ares
Luis Paz-Ares Complutense University of Madrid
Michael Boyer
Michael Boyer University of Utah
Kazuhiko Nakagawa
Kazuhiko Nakagawa Kindai University
Lecia V. Sequist
Lecia V. Sequist Harvard University

External Links

Personal website of Tony Mok

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring pathways beyond traditional medical degrees in the USA can open doors to diverse and rewarding healthcare careers. Many students and professionals are turning to online programs for flexibility, affordability, and faster completion times.

For those interested in mental health, accredited psychiatric np programs offer a direct route into advanced practice psychiatric nursing. These programs can often be completed quickly and entirely online, allowing for career advancement without prolonged time away from work.

If you’re drawn to leadership roles in hospitals or clinics, a health administration degree could be an excellent next step. There are numerous affordable online options, some even recognized for their quality and support.

For those considering a Master’s in Healthcare Administration, researching the cost of mha degree is key, as tuition varies considerably. Affordable programs make advancing your career more accessible.

Lastly, nurses seeking top clinical leadership roles may benefit from a 1 year dnp program online. These short and intensive doctorates prepare graduates for the highest levels of nursing practice.

Best Scientists Citing Tony Mok

Pasi A. Jänne

Pasi A. Jänne

Harvard University

Publications: 188

Yi-Long Wu

Yi-Long Wu

Guangdong Provincial People’s Hospital

Publications: 188

Rafael Rosell

Rafael Rosell

Autonomous University of Barcelona

Publications: 173

Caicun Zhou

Caicun Zhou

Tongji University

Publications: 156

Benjamin Besse

Benjamin Besse

University of Paris-Saclay

Publications: 138

Lecia V. Sequist

Lecia V. Sequist

Harvard University

Publications: 138

Li Zhang

Li Zhang

Sun Yat-sen University

Publications: 137

Myung-Ju Ahn

Myung-Ju Ahn

Sungkyunkwan University

Publications: 133

Kazuhiko Nakagawa

Kazuhiko Nakagawa

Kindai University

Publications: 130

Alice T. Shaw

Alice T. Shaw

Harvard University

Publications: 125

James Chih-Hsin Yang

James Chih-Hsin Yang

National Taiwan University

Publications: 123

Isamu Okamoto

Isamu Okamoto

Kyushu University

Publications: 122

Tetsuya Mitsudomi

Tetsuya Mitsudomi

Kindai University

Publications: 111

Gregory J. Riely

Gregory J. Riely

Memorial Sloan Kettering Cancer Center

Publications: 110

Silvia Novello

Silvia Novello

University of Turin

Publications: 109

Keunchil Park

Keunchil Park

The University of Texas MD Anderson Cancer Center

Publications: 109

Trending Scientists

Zhaoxiang Deng

Zhaoxiang Deng

University of Science and Technology of China

Maria Ibáñez

Maria Ibáñez

Institute of Science and Technology Austria

Steven Porter Hotelling

Steven Porter Hotelling

Apple (United States)

Mark C. Herzberg

Mark C. Herzberg

University of Minnesota

Flore Rozenberg

Flore Rozenberg

Université Paris Cité

Koichi Noguchi

Koichi Noguchi

Hyogo College of Medicine

Steve Frolking

Steve Frolking

University of New Hampshire

Mikel Latasa

Mikel Latasa

Spanish National Research Council

Mark D. Hulett

Mark D. Hulett

La Trobe University

Kan Wang

Kan Wang

Iowa State University

Daniel Jean Stanley

Daniel Jean Stanley

Smithsonian Institution

Yoon-Seok Chang

Yoon-Seok Chang

Seoul National University

Lin Li

Lin Li

University of Illinois at Chicago

Guolong Cui

Guolong Cui

University of Electronic Science and Technology of China

Joe R. Feagin

Joe R. Feagin

Texas A&M University

Gervasio A. Lamas

Gervasio A. Lamas

Columbia University

Related Medicine Rankings & Guides

2027 Best Nursing Schools in Virginia – Accredited ADN, BSN, MSN Programs

2027 Best Nursing Schools in Virginia – Accredited ADN, BSN, MSN Programs
2027 How Much Do Medical Assistant Programs & Certifications Cost?

2027 How Much Do Medical Assistant Programs & Certifications Cost?
2027 Is Grand Canyon University School of Nursing Worth It?

2027 Is Grand Canyon University School of Nursing Worth It?
2027 Most Affordable Online Licensed Practical Nurse (LPN) Programs

2027 Most Affordable Online Licensed Practical Nurse (LPN) Programs
2027 Most Affordable Online Direct Entry MSN Programs for Non-Nurses

2027 Most Affordable Online Direct Entry MSN Programs for Non-Nurses
2027 Best Online BSN to FNP Programs

2027 Best Online BSN to FNP Programs
2027 Most Affordable Online Medical Billing and Coding Courses

2027 Most Affordable Online Medical Billing and Coding Courses
2027 Best Online CAHME-Accredited MHA Programs

2027 Best Online CAHME-Accredited MHA Programs
2027 Best Nursing Schools in Minnesota – Accredited ADN, BSN, MSN Programs

2027 Best Nursing Schools in Minnesota – Accredited ADN, BSN, MSN Programs
2027 Most Affordable Master’s in Health Science Degrees

2027 Most Affordable Master’s in Health Science Degrees
2027 Most Affordable Online BSN to MSN Bridge Programs

2027 Most Affordable Online BSN to MSN Bridge Programs
2027 Best One-Year Online PMHNP Programs

2027 Best One-Year Online PMHNP Programs
2027 Best Online Surgical Tech Certificate Programs

2027 Best Online Surgical Tech Certificate Programs
2027 Most Affordable Online LPN to RN Degree Programs

2027 Most Affordable Online LPN to RN Degree Programs
2027 Fastest Online MSN in Forensic Nursing Programs

2027 Fastest Online MSN in Forensic Nursing Programs
2027 Best Nurse Practitioner Programs in California – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in California – Accredited Schools Online & Campus
2027 Best Online Nurse Practitioner Degree Programs

2027 Best Online Nurse Practitioner Degree Programs
2027 Fastest Online Medical Assistant Associate Degree Programs

2027 Fastest Online Medical Assistant Associate Degree Programs
2027 Best Occupational Therapy Programs

2027 Best Occupational Therapy Programs
2027 Fastest Online Graduate Certificate Nurse Midwifery Programs

2027 Fastest Online Graduate Certificate Nurse Midwifery Programs
2027 Fastest Online BSN to MSN Bridge Programs

2027 Fastest Online BSN to MSN Bridge Programs

Recently Published Articles

2027 Missouri Nursing License Requirements

2027 Missouri Nursing License Requirements
2027 Fastest Accredited Online Special Education Programs: Accelerated Degrees and Completion Times

2027 Fastest Accredited Online Special Education Programs: Accelerated Degrees and Completion Times
2027 Health Informatics Degree Programs That Meet State Licensure Requirements

2027 Health Informatics Degree Programs That Meet State Licensure Requirements
2027 Best Online Community Health Doctorate Programs for Consulting Careers

2027 Best Online Community Health Doctorate Programs for Consulting Careers
2027 Can You Get Licensed With an Online Applied Psychology Degree? Requirements, Rules, and What to Know

2027 Can You Get Licensed With an Online Applied Psychology Degree? Requirements, Rules, and What to Know
2027 Teaching Degree Master's Programs You Can Start Without Meeting All Requirements

2027 Teaching Degree Master's Programs You Can Start Without Meeting All Requirements
2027 Best Accredited Online Teaching Degree Programs: Compare Tuition, Admissions, and Career Outcomes

2027 Best Accredited Online Teaching Degree Programs: Compare Tuition, Admissions, and Career Outcomes
2027 How to Become a Licensed Therapist (LPC) in Albuquerque, NM

2027 How to Become a Licensed Therapist (LPC) in Albuquerque, NM
2027 How to Become a Physical Education Teacher in Georgia

2027 How to Become a Physical Education Teacher in Georgia
2027 Online Educational Leadership Degree Programs Costs: Tuition & Fees

2027 Online Educational Leadership Degree Programs Costs: Tuition & Fees
2027 How to Become a Credentialing Specialist: Education, Salary, and Job Outlook

2027 How to Become a Credentialing Specialist: Education, Salary, and Job Outlook
2027 How to Become a Preschool Teacher Assistant in Utah: Requirements & Certification

2027 How to Become a Preschool Teacher Assistant in Utah: Requirements & Certification
2027 Is Entrepreneurship a Hard Major? What Students Should Know

2027 Is Entrepreneurship a Hard Major? What Students Should Know
2027 How to Become a Teacher in Ohio – What Degree Do You Need to Be a Teacher?

2027 How to Become a Teacher in Ohio – What Degree Do You Need to Be a Teacher?
2027 How to Become a Medical Biller & Coder in Wichita, KS: Education Requirements & Certification

2027 How to Become a Medical Biller & Coder in Wichita, KS: Education Requirements & Certification
2027 Industrial Organizational Psychology Degree Master's Programs Accepting Students Now

2027 Industrial Organizational Psychology Degree Master's Programs Accepting Students Now
2027 Best Online Intelligence Degree Master's Programs for Working Professionals

2027 Best Online Intelligence Degree Master's Programs for Working Professionals
2027 How to Become a Supply Chain Manager: Salary & Career Paths

2027 How to Become a Supply Chain Manager: Salary & Career Paths
2027 How Long Does It Take to Become a Licensed Counselor?

2027 How Long Does It Take to Become a Licensed Counselor?
2027 Entry-Level Jobs With a Christian Ministry Degree

2027 Entry-Level Jobs With a Christian Ministry Degree
2027 ABA Fellowship Opportunities for Graduate Students in 2026

2027 ABA Fellowship Opportunities for Graduate Students in 2026